Switzer TV | Stocks slide, is now the time to buy anyway? Red flags for SpaceX IPO

Daniel Tillett, Racura Oncology: the Australian biotech that says it has cracked a cancer target left untouched for 40 years, and why its shareholders keep backing it. Watch here.